| Serial Number | 79337464 |
| Word Mark | SCTBIO |
| Filing Date | Wednesday, February 9, 2022 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, March 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 23, 2024 |
| Goods and Services | Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others |
| Goods and Services | Labeling, relabeling, storage and distribution of cell therapy materials |
| Goods and Services | Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 103, 106, 100 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SCT CELL MANUFACTURING S.R.O. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | CZ-170 00 PRAGUE 7 CZ |
| Party Name | SCTbio a.s. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 98 - Unknown |
| Address | CZ |
| Event Date | Event Description |
| Wednesday, April 3, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 3, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, March 20, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 20, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 20, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 20, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 20, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 5, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, March 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 4, 2024 | ASSIGNED TO LIE |
| Friday, February 16, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, February 16, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 16, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 13, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Friday, October 13, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Friday, October 13, 2023 | PETITION TO REVIVE-GRANTED |
| Friday, October 13, 2023 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, October 3, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 13, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 13, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, August 14, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, August 14, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, August 14, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, February 14, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, January 25, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, January 25, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, January 20, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, December 25, 2022 | CHANGE OF OWNER RECEIVED FROM IB |
| Thursday, November 24, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, November 23, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 22, 2022 | ASSIGNED TO EXAMINER |
| Friday, November 18, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, April 12, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 7, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |